Related Experiment Video
Updated: Aug 15, 2026

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Role of N-methyl-D-aspartate receptor in hyperoxia-induced lung injury
FeiGe Tang1, ShaoJie Yue, ZiQiang Luo
1Department of Pediatrics, XinHua Hospital, Shanghai Second Medical University, Shanghai, China.
Abstract:
Glutamate (Glu) N-methyl-D-aspartate (NMDA) receptor is present in the lungs, and NMDA receptor antagonist MK-801 attenuates oxidant lung injury. We hypothesized that Glu excitotoxicity may participate in the pathogenesis of hyperoxia-induced lung injury. To determine possible pulmonary protective effects, we administered 0.05 ml/kg MK-801 or saline intraperitoneally daily to neonatal rats exposed to more than 95% oxygen in air. After 7 days, MK-801 decreased the hyperoxia-associated elevation of wet-to-dry lung weight, total leukocyte and neutrophil counts, total protein and lactate dehydroase in BAL fluid, total myeloperoxidase activity, and lung pathological injury. MK-801 inhibited hyperoxia-associated increments in reactive oxygen species production and NF-kappaB production. Hence, NMDA receptor antagonist MK-801 ameliorates hyperoxia-induced lung injury in neonatal rats, and is associated with decreased reactive oxygen species and NF-kappaB. We conclude that Glu may play an important role in hyperoxia-induced lung injury by activation of NMDA receptor.
Insights
The NMDA receptor antagonist MK-801 protects neonatal rats from hyperoxia-induced lung injury by reducing inflammation and oxidative stress. Glutamate excitotoxicity plays a role in this lung injury.
Area of Science:
- Pulmonary Medicine
- Neuroscience
- Toxicology
Background:
- Glutamate (Glu) N-methyl-D-aspartate (NMDA) receptors are found in the lungs.
- NMDA receptor antagonist MK-801 has shown potential in mitigating oxidant lung injury.
- Hyperoxia-induced lung injury is a significant concern in neonatal care.
Purpose of the Study:
- To investigate the role of Glu excitotoxicity in hyperoxia-induced lung injury.
- To determine the pulmonary protective effects of the NMDA receptor antagonist MK-801 in neonatal rats.
Main Methods:
- Neonatal rats were administered MK-801 or saline intraperitoneally daily.
- Rats were exposed to hyperoxia (more than 95% oxygen in air) for 7 days.
- Evaluated lung injury markers including wet-to-dry lung weight, BAL fluid analysis, myeloperoxidase activity, and pathological injury.
Main Results:
- MK-801 treatment significantly reduced hyperoxia-associated increases in lung wet-to-dry weight, leukocyte and neutrophil counts, and protein and LDH levels in BAL fluid.
- MK-801 administration attenuated total myeloperoxidase activity and improved lung pathology.
- The treatment inhibited hyperoxia-induced increments in reactive oxygen species and NF-kappaB production.
Conclusions:
- NMDA receptor antagonist MK-801 ameliorates hyperoxia-induced lung injury in neonatal rats.
- The protective effects are associated with decreased reactive oxygen species and NF-kappaB.
- Glutamate may play a critical role in hyperoxia-induced lung injury through NMDA receptor activation.
Related Concept Videos
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Physiological Control of Respiration
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
